Danny Vesprini, Peter Chung, Shaun Tolan, Mary Gospodarowicz, Michael Jewett, Martin O'Malley, Joan Sweet, Malcolm Moore, Tony Panzarella, Jeremy Sturgeon, Linda Sugar, Lynn Anson-Cartwright and Padraig Warde Utility of serum tumor markers during surveillance for stage I seminoma Cancer 118
Version of Record online: 19 APR 2012 | DOI: 10.1002/cncr.27539
In patients with stage I seminoma who are managed with surveillance, following serum tumor marker levels does not aid in the early diagnosis of disease relapse and, thus, can be safely discontinued.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field